Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Appili Therapeutics announces amendment to arrangement agreement.
$ADTX (+64.4% pre) Aditxt, Inc (ADTX) and Evofem $EVFM Amend and Restate Merger Agreement, now Target September 30 Closing - SI https://t.co/eFLb4vEmiu
From $ADTX PR today: Evofem investors are saying "i changed my mind, i want nothing to do with this company anymore, give me cash instead of shares" And the stock goes up 100% lol https://t.co/palhc0MrXS
Aditxt and Evofem have amended and restated their merger agreement, targeting a closing date of September 30. Evofem investors are opting for cash over shares, leading to a surge in the stock price, with Aditxt's stock rising significantly pre-market.
